Pharmaion
+1 8448850006     sales@pharmaion.com
Report Description

United States Autoimmune Disorders Diagnostics Market Opportunities, 2020

United States Autoimmune Disorders Diagnostics Market Opportunities, 2020
  • Publish Date:November, 2015
  • Format : PDF
  • Pages : 89

Autoimmune disorders occur when a person’s immune system attacks his/her own body; and for detecting these disorders and prescribing required treatments, various laboratory tests are performed. Increasing healthcare expenditure, rapidly rising demand for autoimmune disease diagnostics and various ongoing technological advancements leading to the advent of innovative diagnostic procedures are some of the major factors anticipated to drive the United States autoimmune disorders diagnostics market over the next five years. Furthermore, growing disease burden of various autoimmune disorders, especially Rheumatoid Arthritis, Type 1 Diabetes, Multiple Sclerosis, Systemic Lupus Erythematosus (SLE), Inflammatory Bowel Disease (IBD), Psoriasis and Autoimmune Thyroiditis, is expected to boost the US autoimmune disorders diagnostics market through 2020.

According to Pharmaion report, United States Autoimmune Disorders Diagnostics Market Opportunities, 2020, the autoimmune disorders diagnostics market in the United States is anticipated to cross US$ 6 billion by 2020. On the basis of target disease, the market is broadly segmented into two categories, namely, systemic autoimmune disorders diagnostics and localized autoimmune disorders diagnostics. Among these two categories, systemic autoimmune disorders diagnostics segment dominated the United States autoimmune disorders diagnostics market in 2014. The segment is anticipated to continue its dominance through 2020 on account of increasing ongoing research activities that are focussed on developing tests and technologies that would precisely detect the abnormalities in the organ functioning and thus deliver faster diagnosis. The largest market share in the United States autoimmune disorders diagnostics market was captured by the South-East region, followed by the Midwest, North-East, West and South-West regions. Some of the major players operating in United States autoimmune disorders diagnostics market include Bio-Rad Laboratories, Inc., Roche Diagnostics Corporation, Abbott Laboratories, Danaher Corporation and Siemens Healthcare Diagnostics, Inc., among others. United States Autoimmune Disorders Diagnostics Market Opportunities, 2020discusses the following aspects related to United States autoimmune disorders diagnostics market:

·         United States Autoimmune Disorders Diagnostics Market Size, Share & Forecast

·         Segmental Analysis – By Target Disease, By Test, By Technology & By Region

·         Policy & Regulatory Landscape

·         Changing Market Trends & Emerging Opportunities

·         Competitive Landscape & Strategic Recommendations

Why You Should Buy This Report?

·         To identify the on-going trends and anticipated growth in the next five years

·         To gain competitive knowledge of leading market players

·         To avail 10% customization in the report without any extra charges and get the research data or trends added in the report as per the buyer’s specific needs      

Report Methodology

The information contained in this report is based upon both primary and secondary sources. Primary research included interviews with diagnostics device manufacturers and industry experts. Secondary research included an exhaustive search of relevant publications like company annual reports, financial reports and other proprietary databases.

Please Select Format

Single User License

$3000

Single User License Print

$3500

Enterprise License

$5000

For Queries Please Contact us

sales@pharmaion.com

+1 646 862 0089

10% Customization